Severin Schwan

Schwan serves as the Chief Executive Officer of F. Hoffmann-La Roche Ltd.

Prior to being the Chief Executive Officer of Roche Group, he was:

• Group Chief Executive Officer Roche Pharmholding B.v. since March 2008.
• Group Chief Executive Officer of Roche Holding AG at Roche Pharma AG
• Group Chief Executive Officer of Roche Diagnostics Corporation, a Diagnostics Divisions of Roche Holding Ag since January 1, 2006.
• Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006.
• Director of Roche Holdings, Inc. since April 29, 2008 and Roche Holding Ag 2013.

He previously served as:

• Chief Executive Officer Division Roche Diagnostics from 2006 to 2008
• Head of Diagnostics Asia-Pacific of Roche Holding Ag from 2004 to January 1, 2006.
• Head of Global Finance & Services for the Diagnostics Division from 2000 to 2004. He served as a Director of Chugai Pharmaceutical Co. Ltd., and Genentech, Inc.
• Head Finance & Informatics of Roche Grenzach and Member of the Executive Board of Roche Deutschland Holding GmbH from 1998 to 2000.
• Head Finance & Administration at Roche Brussels from 1995 to 1998.
• Trainee of Corporate Finance at Roche Basel from 1993 to 1995

He served on the board at Chugai Pharmaceutical Co., Ltd. and is the Vice-President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and a member of International Business Leaders Advisory Council for the Mayor of Shanghai. He is also on the Board of Directors at Credit Suisse (Schweiz) AG.[2]

Dr. Schwan holds Degree in Economics from University of Innsbruck, University of York and University of Oxford Mag. rer.soc.oec. (Innsbruck, 1991) and Law from University of Innsbruck Mag. iur. (Innsbruck, 1991) and Doctorate in Law from University of Innsbruck Research studies at University Louvain, Belgium Dr. iur. (Innsbruck, 1993).[3]